Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ambroxol inhalation solution for mucus symptoms in lower respiratory tract infection
CTR20190449Phase 3Active
- Sponsor
- Aonuo Pharmaceutical
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ambroxol in pulmonary infection, chronic bronchitis (CB), pneumonia, chronic obstructive pulmonary disease (COPD), bronchiectasis, sponsored by Aonuo Pharmaceutical. Started Mar 2019; status: active.
02
Drugs
ambroxol
03
Conditions
pulmonary infectionchronic bronchitis (CB)pneumoniachronic obstructive pulmonary disease (COPD)bronchiectasis
Beyond the preview
Go deeper on CTR20190449.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20190449.